10.07.14
Almac has expanded its UK commercial packaging facility, investing in a new humidity controlled blister packaging suite, along with off-line blister printing. The expansion included extensive suite modifications for processing humidity sensitive drug products, installation of a new Noack 623 blister line, a custom designed desiccant feeder, and an off-line Hapa Blister-Jet printer.
The Noack blister line provides added flexibility for processing larger blister sizes and multi-product blister formats, and can be configured to process both thermoform and coldform materials, with maximum blister sizes of 220mm x 155mm. The off-line Hapa Blister-Jet augments the company’s “just-in-time” production by printing country-specific artwork and variable data on each individual blister pocket.
David Downey, Almac’s vice president of commercial operations said, “This co-investment allows Almac to address complex packaging challenges associated with innovative drug products that require enhanced environmental controls but, importantly, also provides our partners with the option to address modest country-specific market volumes, by off-line printing blank blisters through the Hapa unit. This solution will be of significant value to those companies launching orphan and niche blistered drug products into EU and ROW markets, many of which Almac already support.”
The Noack blister line provides added flexibility for processing larger blister sizes and multi-product blister formats, and can be configured to process both thermoform and coldform materials, with maximum blister sizes of 220mm x 155mm. The off-line Hapa Blister-Jet augments the company’s “just-in-time” production by printing country-specific artwork and variable data on each individual blister pocket.
David Downey, Almac’s vice president of commercial operations said, “This co-investment allows Almac to address complex packaging challenges associated with innovative drug products that require enhanced environmental controls but, importantly, also provides our partners with the option to address modest country-specific market volumes, by off-line printing blank blisters through the Hapa unit. This solution will be of significant value to those companies launching orphan and niche blistered drug products into EU and ROW markets, many of which Almac already support.”